Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Fate Therapeutics (FATE)

Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Fate Therapeutics: Q1 Earnings Snapshot AP - Thu May 9, 3:21PM CDT

Fate Therapeutics: Q1 Earnings Snapshot

FATE : 3.16 (-1.86%)
Wall Street - Fearless girl standing tall -xHUZuSwVJg4-unsplash
5 Russell 2000 Stocks Outperforming the 'Magnificent Seven' in 2024 Barchart - Wed Mar 13, 12:24PM CDT

The "Magnificent Seven" have lost some momentum in 2024, just as small-caps are starting to come on strong. Here's a closer look at five Russell 2000 stocks that are crushing the performance of their mega-cap...

GOOGL : 185.82 (+0.31%)
AMZN : 197.59 (-1.21%)
AAPL : 221.55 (+0.58%)
META : 509.96 (+0.09%)
MSFT : 460.77 (+0.32%)
NVDA : 128.28 (+4.57%)
TSLA : 246.39 (+6.54%)
MAGS : 47.94 (+1.68%)
$IUXX : 20,186.63 (+0.87%)
VKTX : 50.47 (-2.08%)
SOUN : 3.93 (-0.25%)
APGE : 37.50 (-1.86%)
Fate Therapeutics: Q4 Earnings Snapshot AP - Mon Feb 26, 3:08PM CST

Fate Therapeutics: Q4 Earnings Snapshot

FATE : 3.16 (-1.86%)
Fate Therapeutics: Q3 Earnings Snapshot AP - Wed Nov 8, 2023

Fate Therapeutics: Q3 Earnings Snapshot

FATE : 3.16 (-1.86%)
Fate Therapeutics: Q2 Earnings Snapshot AP - Tue Aug 8, 2023

Fate Therapeutics: Q2 Earnings Snapshot

FATE : 3.16 (-1.86%)
Why Shares of Fate Therapeutics Soared This Week Motley Fool - Fri Jun 16, 2023

The company's shares bounced back after a stock sale last week.

JNJ : 145.69 (-0.23%)
OPHLY : 4.5600 (-0.87%)
FATE : 3.16 (-1.86%)
MFG : 4.32 (-0.46%)
Fate Therapeutics: Q1 Earnings Snapshot AP - Wed May 3, 2023

Fate Therapeutics: Q1 Earnings Snapshot

FATE : 3.16 (-1.86%)
FINAL DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Fate Therapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important March 22 Deadline in Securities Class Action – FATE Business Wire - Wed Mar 22, 2023

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fate Therapeutics, Inc. (NASDAQ: FATE) between April 2, 2020 and January 5, 2023, both dates inclusive (the...

FATE : 3.16 (-1.86%)
FATE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Fate Therapeutics, Inc. and Encourages Investors to Contact the Firm Business Wire - Tue Mar 21, 2023

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Fate Therapeutics, Inc. (“Fate” or the “Company”)...

FATE : 3.16 (-1.86%)
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fate Therapeutics, Inc. (FATE) Business Wire - Tue Mar 21, 2023

The Law Offices of Frank R. Cruz reminds investors of the upcoming March 22, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Fate Therapeutics,...

FATE : 3.16 (-1.86%)

Barchart Exclusives

Large Unusual Activity in Tesla Put Options Dominates the Options Market Today Barchart - Wed Jul 3, 12:00PM CDT
Today there is large, unusual activity in Tesla options. This is almost certainly due to the recent rise in TSLA stock. The puts highlight investors' concerns about Tesla stock, but they also present good income plays. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot